New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.
There are steps physicians can take to prepare their patients with pulmonary issues for the changing of the seasons.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback